Somatic Mutations and Clonal Hematopoiesis
Unexpected Potential New Drivers of Age-Related Cardiovascular Disease
Jump to
- Article
- Abstract
- Aging and Cardiovascular Disease, an Incompletely Understood Connection
- Somatic Mutations in the Hematopoietic System and Atherosclerotic CVD: Evidence From Human Studies
- Somatic Mutations in the Hematopoietic System and Atherosclerotic CVD: Evidence From Mouse Studies, the Case of TET2
- Somatic Mutation-Driven Clonal Hematopoiesis and Atherosclerotic CVD Beyond TET2: Other Genes and Mechanisms?
- Somatic Mutation-Driven Clonal Hematopoiesis: Many Open Questions
- Conclusions
- Acknowledgments
- Sources of Funding
- Disclosures
- Footnotes
- References
- Figures & Tables
- Info & Metrics
- eLetters

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Increasing evidence shows that conventional cardiovascular risk factors are incompletely predictive of cardiovascular disease, particularly in elderly individuals, suggesting that there may still be unidentified causal risk factors. Although the accumulation of somatic DNA mutations is a hallmark of aging, its relevance in cardiovascular disease or other age-related conditions has been, with the exception of cancer, largely unexplored. Here, we review recent clinical and preclinical studies that have identified acquired mutations in hematopoietic stem cells and subsequent clonal hematopoiesis as a new cardiovascular risk factor and a potential major driver of atherosclerosis. Understanding the mechanisms underlying the connection between somatic mutation-driven clonal hematopoiesis and cardiovascular disease will be highly relevant in the context of personalized medicine, as it may provide key information for the design of diagnostic, preventive, or therapeutic strategies tailored to the effects of specific somatic mutations.
- © 2018 American Heart Association, Inc.
American Heart Association Professional?
Log in using your username and password
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
This Issue
Jump to
- Article
- Abstract
- Aging and Cardiovascular Disease, an Incompletely Understood Connection
- Somatic Mutations in the Hematopoietic System and Atherosclerotic CVD: Evidence From Human Studies
- Somatic Mutations in the Hematopoietic System and Atherosclerotic CVD: Evidence From Mouse Studies, the Case of TET2
- Somatic Mutation-Driven Clonal Hematopoiesis and Atherosclerotic CVD Beyond TET2: Other Genes and Mechanisms?
- Somatic Mutation-Driven Clonal Hematopoiesis: Many Open Questions
- Conclusions
- Acknowledgments
- Sources of Funding
- Disclosures
- Footnotes
- References
- Figures & Tables
- Info & Metrics
Article Tools
- Somatic Mutations and Clonal HematopoiesisJosé J. Fuster and Kenneth WalshCirculation Research. 2018;122:523-532, originally published February 1, 2018https://doi.org/10.1161/CIRCRESAHA.117.312115
Citation Manager Formats